Overview / Abstract: |
Filmed at a prominent infectious disease meeting in October 2018, experts James Lewis, PharmD and James McKinnell, MD offer a lively discussion and clinical analysis of current optimal management of multidrug-resistant Gram-negative pseudomonas-based pneumonia infections in the context of a complex patient case. The purpose of this activity is to update physicians and pharmacists that may come in clinical contact with serious, treatment-refractory bacterial infections such as Gram-negative infections with the latest clinical evidence, practice guidelines, and antimicrobial stewardship protocols for providing optimal treatment. Upon completion of this activity, participants will be able to: This activity is intended for ID specialists, hospitalists, pulmonologists, critical care specialists, internists, and other physicians, pharmacists, nurse practitioners, and physician assistants who care for patients at risk of serious infection. Certified for physicians and pharmacists. |
Expiration |
Nov 30, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.5 |
Accreditation |
ACCME, ACPE |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
James Lewis, II, PharmD, FIDSA James McKinnell, MD |
Activity Specialities / Related Topics |
Acute Care, Antibiotics / Anti-Infectives, Contamination & Infection Control, Critical Care / Intensive Care, Emergency Medicine, Hospital-Acquired Infections, Infectious Disease, Pulmonary Medicine / COPD, Surgery, Urology |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Merck & Company. |
Keywords / Search Terms |
ACHL Gram-negative; Gram-negative infections, HAPs; VAPs; Hospital-acquired pneumonias; Ventilator-associated pneumonias; cUTIs, antimicrobial stewardship, cephalosporins; IDSA/SHEA guidelines; pseudomonas; antibiotic resistance; resistant pathogens, combination therapy, combination antibiogram, antibiogram, clinical breakpoints, James Lewis, James McKinnell, Merck & Company, IDWeek, IDWeek 2018, IDWeek Symposium, infectious diseas Free CE CME Live CE CME |